Boris Slobodin
- Molecular Biology top 10%
- Cancer Research top 10%
- Infectious Diseases top 10%
- Electrical and Electronic Engineering
- Oncology
- Co-authors
- Jeffrey E. GerstRan ElkonReuven AgamiRuiqi HanJoachim A.F. Oude VrielinkFabricio Loayza‐PuchVittorio CalderoneRivka Dikstein
- Topics
- RNA and protein synthesis mechanisms (8 papers)RNA Research and Splicing (8 papers)RNA modifications and cancer (7 papers)
- Journals
- NatureCellNucleic Acids Research
- Partner nations
- IsraelNetherlandsAustria
In The Last Decade
Boris Slobodin
11 papers receiving 944 citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Molecular Biology 825
- Cancer Research 190
- Infectious Diseases 121
- Electrical and Electronic Engineering 86
- Oncology 59
Countries citing papers authored by Boris Slobodin
This map shows the geographic impact of Boris Slobodin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Slobodin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Slobodin more than expected).
Fields of papers citing papers by Boris Slobodin
This network shows the impact of papers produced by Boris Slobodin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Slobodin. The network helps show where Boris Slobodin may publish in the future.
Co-authorship network of co-authors of Boris Slobodin
This figure shows the co-authorship network connecting the top 25 collaborators of Boris Slobodin. A scholar is included among the top collaborators of Boris Slobodin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Slobodin. Boris Slobodin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Exclusion of m6A from splice-site proximal regions by the exon junction complex dictates m6A topologies and mRNA stabilitybreakdown → | 123 |
| 3 | 26 | |
| 4 | SARS-CoV-2 uses a multipronged strategy to impede host protein synthesisbreakdown → | 160 |
| 5 | 47 | |
| 6 | 21 | |
| 7 | 348 | |
| 8 | 37 | |
| 9 | 55 | |
| 10 | 32 | |
| 11 | 71 | |
| 12 | 31 |
About Boris Slobodin
Boris Slobodin is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cell Biology, having authored 12 papers that have together received 951 indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (8 papers), RNA Research and Splicing (8 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Cancer Research (190 citations), Molecular Biology (825 citations) and Infectious Diseases (121 citations). Boris Slobodin has collaborated with scholars based in Israel, Netherlands and Austria. Frequent co-authors include Jeffrey E. Gerst, Ran Elkon, Reuven Agami, Ruiqi Han, Joachim A.F. Oude Vrielink, Fabricio Loayza‐Puch, Vittorio Calderone, Rivka Dikstein, B. M. Zuckerman and Igor Ulitsky. Their work appears in journals such as Nature, Cell and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.